Form 8-K - Current report:
SEC Accession No. 0000950170-25-050406
Filing Date
2025-04-03
Accepted
2025-04-03 16:15:24
Documents
11
Period of Report
2025-03-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rkda-20250328.htm   iXBRL 8-K 44045
  Complete submission text file 0000950170-25-050406.txt   156752

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rkda-20250328.xsd EX-101.SCH 24852
13 EXTRACTED XBRL INSTANCE DOCUMENT rkda-20250328_htm.xml XML 4671
Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37383 | Film No.: 25809661
SIC: 1311 Crude Petroleum & Natural Gas
(CF Office: 01 Energy & Transportation)